β-Cell regeneration mediated by human bone marrow mesenchymal stem cells

PLoS ONE

Volumn 7, Issue 8, 2012, Pages

  Milanesi, Anna ^a,b   Lee, Jang Won ^a   Li, Zhenhua ^a   da Sacco, Stefano ^c   Villani, Valentina ^c   Cervantes, Vanessa ^a   Perin, Laura ^c   Yu, John S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; SOMATOMEDIN RECEPTOR; TRANSCRIPTION FACTOR PDX 1; VASCULOTROPIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CELL DIFFERENTIATION; CELL FUNCTION; CELL REGENERATION; CELL VOLUME; CONTROLLED STUDY; DIABETES MELLITUS; DNA MODIFICATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; OVERALL SURVIVAL; PANCREAS ISLET BETA CELL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ADULT; ANIMALS; BONE MARROW CELLS; DIABETES MELLITUS, EXPERIMENTAL; HOMEODOMAIN PROTEINS; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN-SECRETING CELLS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; REGENERATION; SIGNAL TRANSDUCTION; STREPTOZOCIN; TRANS-ACTIVATORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; MUS;

EID: 84864648441     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0042177     Document Type: Article

References (55)

1. Ianus A, Holz GG, Theise ND, Hussain MA, (2003) In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111: 843-850.
2. Zhao M, Amiel SA, Ajami S, Jiang J, Rela M, et al. (2008) Amelioration of streptozotocin-induced diabetes in mice with cells derived from human marrow stromal cells. PLoS One 3: e2666.
3. Hess D, Li L, Martin M, Sakano S, Hill D, et al. (2003) Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 21: 763-770.
4. Alvarez SS, Jimenez LM, Murillo AZ, Gomez IG, Ligero JM, et al. (2006) A new approach for bone marrow-derived stem cells intrapancreatic autotransplantation in diabetic rats. Microsurgery 26: 539-542.
5. Banerjee M, Kumar A, Bhonde RR, (2005) Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun 328: 318-325.
6. ksadHasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, et al. (2007) Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 148: 2006-2015.
7. Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, et al. (2006) Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD/scid mice. Proc Natl Acad Sci U S A 103: 17438-17443.
8. Urban VS, Kiss J, Kovacs J, Gocza E, Vas V, et al. (2008) Mesenchymal stem cells cooperate with bone marrow cells in therapy of diabetes. Stem Cells 26: 244-253.
9. Fiorina P, Jurewicz M, Augello A, Vergani A, Dada S, et al. (2009) Immunomodulatory function of bone marrow-derived mesenchymal stem cells in experimental autoimmune type 1 diabetes. J Immunol 183: 993-1004.
10. Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Yanez AJ, et al. (2008) Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant 14: 631-640.
11. Ezquer F, Ezquer M, Simon V, Conget P, (2011) The antidiabetic effect of MSCs is not impaired by insulin prophylaxis and is not improved by a second dose of cells. PLoS One 6: e16566.
12. Milanesi A, Lee JW, Xu Q, Perin L, Yu JS, (2011) Differentiation of nestin-positive cells derived from bone marrow into pancreatic endocrine and ductal cells in vitro. J Endocrinol 209: 193-201.
13. Kabos P, Ehtesham M, Kabosova A, Black KL, Yu JS, (2002) Generation of neural progenitor cells from whole adult bone marrow. Exp Neurol 178: 288-293.
14. Zeng Z, Yuan X, Liu G, Zeng X, Ng H, et al. (2007) Manipulation of proliferation and differentiation of human bone marrow-derived neural stem cells in vitro and in vivo. J Neurosci Res 85: 310-320.
15. Tang DQ, Cao LZ, Burkhardt BR, Xia CQ, Litherland SA, et al. (2004) In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 53: 1721-1732.
16. Chen LB, Jiang XB, Yang L, (2004) Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol 10: 3016-3020.
17. Karnieli O, Izhar-Prato Y, Bulvik S, Efrat S, (2007) Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation. Stem Cells 25: 2837-2844.
18. Fujitani Y, Fujitani S, Boyer DF, Gannon M, Kawaguchi Y, et al. (2006) Targeted deletion of a cis-regulatory region reveals differential gene dosage requirements for Pdx1 in foregut organ differentiation and pancreas formation. Genes Dev 20: 253-266.
19. Holland AM, Gonez LJ, Naselli G, Macdonald RJ, Harrison LC, (2005) Conditional expression demonstrates the role of the homeodomain transcription factor Pdx1 in maintenance and regeneration of beta-cells in the adult pancreas. Diabetes 54: 2586-2595.
20. Brissova M, Shostak A, Shiota M, Wiebe PO, Poffenberger G, et al. (2006) Pancreatic islet production of vascular endothelial growth factor-a is essential for islet vascularization, revascularization, and function. Diabetes 55: 2974-2985.
21. Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, et al. (2006) The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell 10: 397-405.
22. Nicholson JM, Arany EJ, Hill DJ, (2010) Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat. Exp Biol Med (Maywood) 235: 189-198.
23. Christofori G, Naik P, Hanahan D, (1995) Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet cell tumorigenesis. Mol Endocrinol 9: 1760-1770.
24. Chae HY, Lee BW, Oh SH, Ahn YR, Chung JH, et al. (2005) Effective glycemic control achieved by transplanting non-viral cationic liposome-mediated VEGF-transfected islets in streptozotocin-induced diabetic mice. Exp Mol Med 37: 513-523.
25. Narang AS, Sabek O, Gaber AO, Mahato RI, (2006) Co-expression of vascular endothelial growth factor and interleukin-1 receptor antagonist improves human islet survival and function. Pharm Res 23: 1970-1982.
26. Malek A, Catapano CV, Czubayko F, Aigner A, (2010) A sensitive polymerase chain reaction-based method for detection and quantification of metastasis in human xenograft mouse models. Clin Exp Metastasis 27: 261-271.
27. Kulkarni RN, Jhala US, Winnay JN, Krajewski S, Montminy M, et al. (2004) PDX-1 haploinsufficiency limits the compensatory islet hyperplasia that occurs in response to insulin resistance. J Clin Invest 114: 828-836.
28. Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH, 3rd, et al (2002) The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth. J Clin Invest 110: 1839-1847.
29. Jiang BH, Zheng JZ, Aoki M, Vogt PK, (2000) Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A 97: 1749-1753.
30. Tanabe K, Liu Z, Patel S, Doble BW, Li L, et al. (2008) Genetic deficiency of glycogen synthase kinase-3beta corrects diabetes in mouse models of insulin resistance. PLoS Biol 6: e37.
31. Folli F, Okada T, Perego C, Gunton J, Liew CW, et al. (2011) Altered insulin receptor signalling and beta-cell cycle dynamics in type 2 diabetes mellitus. PLoS One 6: e28050.
32. Hasegawa Y, Ogihara T, Yamada T, Ishigaki Y, Imai J, et al. (2007) Bone marrow (BM) transplantation promotes beta-cell regeneration after acute injury through BM cell mobilization. Endocrinology 148: 2006-2015.
33. Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, et al. (1998) Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140: 947-959.
34. Issbrucker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, et al. (2003) p38 MAP kinase-a molecular switch between VEGF-induced angiogenesis and vascular hyperpermeability. FASEB J 17: 262-264.
35. Lin H, Shabbir A, Molnar M, Yang J, Marion S, et al. (2008) Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J Cell Physiol 216: 458-468.
36. Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, et al. (2005) Vascular endothelial growth factor-expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol 25: 1168-1173.
37. Al-Khaldi A, Eliopoulos N, Martineau D, Lejeune L, Lachapelle K, et al. (2003) Postnatal bone marrow stromal cells elicit a potent VEGF-dependent neoangiogenic response in vivo. Gene Ther 10: 621-629.
38. Iwashita N, Uchida T, Choi JB, Azuma K, Ogihara T, et al. (2007) Impaired insulin secretion in vivo but enhanced insulin secretion from isolated islets in pancreatic beta cell-specific vascular endothelial growth factor-A knock-out mice. Diabetologia 50: 380-389.
39. Nakayama S, Uchida T, Choi JB, Fujitani Y, Ogihara T, et al. (2009) Impact of whole body irradiation and vascular endothelial growth factor-A on increased beta cell mass after bone marrow transplantation in a mouse model of diabetes induced by streptozotocin. Diabetologia 52: 115-124.
40. Sakata N, Chan NK, Chrisler J, Obenaus A, Hathout E, (2010) Bone marrow cell cotransplantation with islets improves their vascularization and function. Transplantation 89: 686-693.
41. Duffy GP, Ahsan T, O'Brien T, Barry F, Nerem RM, (2009) Bone marrow-derived mesenchymal stem cells promote angiogenic processes in a time- and dose-dependent manner in vitro. Tissue Eng Part A 15: 2459-2470.
42. Tamama K, Sen CK, Wells A, (2008) Differentiation of bone marrow mesenchymal stem cells into the smooth muscle lineage by blocking ERK/MAPK signaling pathway. Stem Cells Dev 17: 897-908.
43. Yue WM, Liu W, Bi YW, He XP, Sun WY, et al. (2008) Mesenchymal stem cells differentiate into an endothelial phenotype, reduce neointimal formation, and enhance endothelial function in a rat vein grafting model. Stem Cells Dev 17: 785-793.
44. Gong Z, Niklason LE, (2008) Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 22: 1635-1648.
45. Forte A, Finicelli M, Mattia M, Berrino L, Rossi F, et al. (2008) Mesenchymal stem cells effectively reduce surgically induced stenosis in rat carotids. J Cell Physiol 217: 789-799.
46. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, et al. (2009) Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A 106: 14022-14027.
47. Wang Q, Jin T, (2009) The role of insulin signaling in the development of beta-cell dysfunction and diabetes. Islets 1: 95-101.
48. Matsuoka TA, Kaneto H, Miyatsuka T, Yamamoto T, Yamamoto K, et al. (2010) Regulation of MafA expression in pancreatic beta-cells in db/db mice with diabetes. Diabetes 59: 1709-1720.
49. Assmann A, Hinault C, Kulkarni RN, (2009) Growth factor control of pancreatic islet regeneration and function. Pediatr Diabetes 10: 14-32.
50. Tuttle RL, Gill NS, Pugh W, Lee JP, Koeberlein B, et al. (2001) Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nat Med 7: 1133-1137.
51. Gu Y, Lindner J, Kumar A, Yuan W, Magnuson MA, (2011) Rictor/mTORC2 is essential for maintaining a balance between beta-cell proliferation and cell size. Diabetes 60: 827-837.
52. Andjelkovic M, Alessi DR, Meier R, Fernandez A, Lamb NJ, et al. (1997) Role of translocation in the activation and function of protein kinase B. J Biol Chem. 272: 31515-31524.
53. Brazil DP, Hemmings BA, (2001) Ten years of protein kinase B signalling: a hard Akt to follow. Trends Biochem Sci 26: 657-664.
54. Federici M, Hribal M, Perego L, Ranalli M, Caradonna Z, et al. (2001) High glucose causes apoptosis in cultured human pancreatic islets of Langerhans: a potential role for regulation of specific Bcl family genes toward an apoptotic cell death program. Diabetes 50: 1290-1301.
55. Gratton JP, Morales-Ruiz M, Kureishi Y, Fulton D, Walsh K, et al. (2001) Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem 276: 30359-30365.